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Abstract 
In case of periprosthetic hip infections the implantation of antibiotic-loaded PMMA spacers is 
accepted for an adequate treatment option. Although their indication for the treatment of 
destructive, bacterial infections of the proximal femur would make sense, literature data are 
scarce. Hence, the aim of this study was to evaluate the efficacy of antibiotic-impregnated 
spacers in the treatment of proximal femur infections. 
In 10 consecutive patients (5 M/ 5 F, mean age 66 y.) with bacterial proximal femur infec-
tions, a femoral head/neck resection was prospectively performed with a subsequent im-
plantation of an antibiotic-loaded spacer. The joint-specific outcome was evaluated by the 
Merle d´Aubigne and the Mayo hip score, the general outcome by SF-36. The time periods 
were divided into “infection situation”, “between stages” and meanly 1 year “after prosthesis 
implantation”.  
The spacers were meanly implanted over 90 [155-744] days. In all cases an infection eradi-
cation could be achieved. After infection eradication, a prosthesis implantation was per-
formed in 8 cases. The general scores showed significant increases at each time period. With 
regard to the dimension “pain”, both scores demonstrated a significant increase between 
“infection situation” and “between stages”, but no significance between “between stages” 
and “after prosthesis implantation”.   
Spacers could be indicated in the treatment of proximal femur infections. Besides an infec-
tion eradication, a pain reduction is also possible. 
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Introduction 
The maintenance of the joint function and the 
infection eradication are the treatment aims of bacte-
rial infections of the proximal femur and its bordering 
soft tissues. In case of early infections of a bacterial 
coxitis, local treatment procedures, such as arthro-
tomy and lavage [2], open or arthroscopic joint lavage 
[4], insertion of antibiotic-loaded media [21] and sys-
temic antibiosis [2] usually lead to a successful infec-
tion management. However, these procedures are 
insufficient in the treatment of the destructive, bacte-
rial coxitis or the septic pseudarthrosis of the femoral 
neck after osteosynthesis. Thus, in these cases a 
two-stage treatment is often required. Beyond the 
obligate systemic antibiosis, the common procedure 
includes an excision arthroplasty of the femoral head 
(Girdlestone-hip) with a simultaneous insertion of 
commercial antibiotic-loaded device (beads or colla-
gen sponges) [16-18, 20]. In case of multimicrobial Int. J. Med. Sci. 2009, 6 
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infections, these commercial antibiotic-impregnated 
media cannot provide frequently a sufficient antibi-
otic therapy. Further disadvantages of the Girdle-
stone-hip are the instable joint situation and the 
soft-tissue shortening which may lead to enormous 
problems during the later prosthesis reimplantation 
[5, 14, 24]. 
A modern, innovative procedure for avoidance 
of soft-tissue shortening and provision of sufficient 
infection therapy is the usage of temporary, antibi-
otic-loaded cement spacers [5, 7, 14, 24]. Although 
their indication in the treatment of destructive, bacte-
rial infections of the proximal femur would make 
sense, literature data are scarce [8-9]. 
In this study, we report on the technical proce-
dure and the outcome of our therapy concept using 
antibiotic-impregnated PMMA hip spacers in the 
treatment of proximal femur infections.  
Patients and Methods 
Patients 
Between 2000 and 2004 we performed an exci-
sion arthroplasty of the femoral head/neck in 10 
consecutive patients (5 M, 5 F) due to bacterial infec-
tions of the proximal femur. A total of 11 antibi-
otic-loaded PMMA hip spacers were implanted (Table 
1). At the time of surgery, the mean age of the patients 
was 66 [52-77] years. After infection eradication, a 
prosthesis has been reimplanted in 8 cases. One pa-
tient passed away due to an unclear cause between 
stages, another patient (bilateral spacer implantation) 
due to a cardiomyopathy. In both cases, a reinfection 
could be excluded by magnet resonance imaging 
(MRI). 
Patients’ comorbidities, surgical procedures, 
pathogen organisms, time between stages and fol-
low-up are summarized in Table 1. The diagnostic 
criteria for infection consisted of medical history, 
physical examination, blood results, C-reactive pro-
tein (CRP), erythrocyte sedimentation rate (ESR), ra-
diological findings (x-ray, CT or MRI) and isolation of 
the pathogen organism. In 2 cases, no organism could 
be identified, however, the histopathological findings 
confirmed the diagnosis of an osteomyelitis of the 
femoral head. 
 
Table 1: Patients’ data, surgical procedures, and causative organisms at the site of hip spacer implantation in the treatment 
of coxitis and proximal femur infections after osteosynthesis.  
Patient Age/ 
Gender 
Diagnosis Surgical 
treatment 
Pathogen 
organism 
Time 
between
stages 
[days] 
Follow-up
[days] 
  
  
Comorbidities 
1  61/M  reactive coxitis after 
psoas abscess 
femoral head  
 resection and  
spacer implantation 
n.o.i.  84  684  cerebral infarct, renal 
tuberculosis, heart muscle 
akinesia 
2 65/F  septic  pseudarthrosis 
after osteosynthesis  
for intertrochanteric 
fracture 
dynamic hip screw 
removal, femoral head 
resection and spacer 
implantation 
MRSA 
S. epidermidis
87 473  hyperthyreosis 
3 52/M  destructive  bacterial 
coxitis 
resection arthroplasty, 
beads implantation  
and subsequent  
spacer implantation 
S. aureus  60  405  arterial hypertension, 
hyperuricaemia, obesity, 
diabetes mellitus 
4 66/F  secondary  bacterial 
coxitis after  
pelvic abscess 
femoral head  
 resection and  
spacer implantation 
S. aureus  93  744  arterial hypertension, 
alcohol abuse, 
polyneuropathia 
5 66/M  septic  pseudarthrosis   
after osteosynthesis  
for intertrochanteric  
fracture 
hardware removal, 
femoral head 
resection and spacer 
spacer implantation 
α-haemol. 
streptococci 
192 175  adrenal  adenoma, 
arterial hypertension, 
diabetes mellitus,  
peripheral vascular disease, 
heart insufficiency NYHA II, 
obstructive pulmonal disease 
6 75/F  septic  pseudarthrosis   
after osteosynthesis  
for intertrochanteric 
fracture 
dynamic hip screw 
removal, femoral head 
resection and spacer 
implantation 
n.o.i.  73  210  heart infarct, chronic venous 
stasis, gastric ulcer 
7 77/M  septic  pseudarthrosis 
after osteosynthesis 
for intertrochanteric 
fracture 
dynamic hip screw 
removal, femoral  
head resection 
and spacer 
implantation 
S. aureus  134  344  arterial hypertension, 
alcohol abuse, chronic 
renal insufficiency, coronar 
heart disease, cerebral 
atrophy 
8 70/F  destructive  bacterial 
coxitis 
femoral head  
 resection and  
spacer implantation 
S. aureus  113  155  obesity, arterial hypertension, 
reflux oesophagitis, local 
hypernephroma relapse  
9 72/M  bilateral  destructive 
bacterial coxitis  
bilateral abscess 
debridement, femoral 
S. aureus  p.p.a.  p.p.a.  lunge edema, hemicolectomy, 
sepsis Int. J. Med. Sci. 2009, 6 
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following bilateral 
psoas abscess 
head resection and 
spacer implantation 
10 52/F  destructive  bacterial 
coxitis 
femoral head  
 resection and  
spacer implantation 
n.o.i. p.p.a.  p.p.a.  arterial hypertension, 
heart insufficiency, 
depression, 
spondylodiscitis L5/S1 
n.o.i.: no organism identified; p.p.a.: patient passed away 
 
Methods 
Surgical approach for spacer implantation 
Via a transgluteal approach the proximal femur 
was demonstrated. After radical debridement of po-
tentially infected and necrotic soft-tissues, the femoral 
head was resected under consideration of the later 
implantation of the prosthesis into the proximal fe-
mur. Tissue samples (bone- and soft tissue) were sent 
for bacteriological and histological examination. After 
proper leg positioning, the femur was prepared with 
the rasps of our endoprosthesis systems (Bicontact®, 
Fa. Aesculap, Tuttlingen, Germany) for the spacer 
implantation. Afterwards, pulsatile lavage was per-
formed with approximately 15 l Ringer’s solution PL 
2511 (Fa. Fresenius-Kabi, Bad-Homburg, Germany). 
At the same time, another team in the surgery 
room had been producing the spacer by using a 
CAD-planned and CNC-milled, two-parted mould of 
polyoxymethylene [1]. The bone cement used in all 
cases was Refobacin-Palacos ® (Fa. Merck, Darmstadt, 
Gemany), each spacer was loaded with 4 g vancomy-
cin (Fa. cell pharen GmbH, Hannover, Germany) per 
80 g cement. In one case, 800 mg teicoplanin were 
used due to a vancomycin allergy of the patient. 
All spacers have been fixed to the proximal fe-
mur according either to the “glove”-technique [1] or 
to a “press-fit”-method. Thus, a rotation-secure im-
plantation could be achieved in the proximal marrow 
cavity of the femur. After spacer reduction, a redon 
drain was placed at the spacer’s head and another one 
subfascial. The wound was then closed in layers.  
Postoperative treatment 
Antibiosis: 
After consultation with our Microbiologic Insti-
tute and under narrow CRP monitoring, intravenous 
antibiotics have been administered for the first 4 
weeks and subsequently oral antibiotics for another 
two weeks, depending on the sensitivity profile of the 
particular causative organism. Both patients with no 
isolated organisms were treated with flucloxacillin 
and clindamycin, respectively. The systemic therapy 
was ended if the CRP level was normal after these 6 
weeks. 14 days after ending of the antibiosis and if the 
CRP has returned to normal levels, the prosthesis im-
plantation could be planned.  
Physiotherapy: 
Postoperatively, an immediate mobilisation of 
the patients with crutches under contact weight 
bearing (spacer not stable under total weight bearing) 
was aimed. The desired mobility of the operated hip 
joint should conform to the one of a hip joint with a 
standard prosthesis. 
Surgical approach for prosthesis implantation: 
After demonstration of the spacer via the trans-
gluteal approach, spacer removal, debridement and 
pulsatile lavage, we could implant a standard pros-
thesis type Aesculap Bicontact with a screw cup type 
SC (Fa. Aesculap, Tuttlingen, Germany)  in 7 cases 
(Fig. 1). In one case a Link-revision stem (Fa. Walde-
mar Link, Hamburg, Germany) was implanted, 
whereas the acetabular cup was also a screw cup SC. 
 
 
 
 
Fig. 1: Left: Destructive bacterial coxitis; Middle: Spacer 
implantation between stages; Right: 3 months later and after 
infection eradication, a prosthesis implantation (SC
® cup, 
Bicontact
® stem, Fa. Aesculap, Tuttlingen, Germany) has 
been performed. 
 
 
Follow-up after prosthesis implantation 
Physical examination: 
Besides mobility and leg length measurement, 
the maximal walking distance, pain persistence and Int. J. Med. Sci. 2009, 6 
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requirement for walking aids were evaluated. 
Scores: 
Joint specific outcome: 
The joint specific outcome of the patients was 
evaluated by the Merle d´Aubigne [15] and Mayo Hip 
Score [10]. The selected time periods were “infection 
situation” (before the spacer implantation), “between 
stages” (after infection eradication, period between 
stages)) and “after prosthesis implantation”, at a 
mean follow-up of 1 year [155/744 days]. 
General outcome: 
The outcome of the patients was exclusively 
evaluated at the follow-up by the SF-36 [3], a ques-
tionnaire about the health related life quality. The 
evaluated scores of the patients were compared to 
ones of a control group of similar age and gender, 
representative of the german population.  
Statistics: 
Due to the small sample size and the 
non-symmetrical distribution, the median and both 
extreme values are shown. Statistical analysis was 
performed with the Wilcoxon-test [28], significance 
niveau was defined for a p < 0.05. All statistical 
evaluation was carried out with the software program 
SPSS 12.0 (Fa. SPSS GmbH, Munich, Germany). 
 
 
Results 
Only the results of the eight patients with a 
prosthesis reimplantation have been evaluated. In all 
cases an infection eradication could be achieved. The 
spacers were meanly implanted for 90 [60/192] days. 
1. Complications 
A spacer dislocation occurred in one case. 
Treatment consisted of closed reduction and immobi-
lization in a Newport orthesis (Fa. Ormed, Freiburg, 
Germany). The dislocation cause was a fracture of the 
dorsal acetabular lip which occurred during the 
femoral head dislocation. During stages, the patient 
suffered from a thrombosis, probably due to the 
tightness of the orthesis. One year later, we diagnosed 
in the same patient a septic prosthesis loosening 
again. The infection treatment consisted again of a 
spacer implantation. After infection eradication, a 
prosthesis was reimplanted. At a further follow-up of 
24 months, no reinfection or infection persistence oc-
curred. 
2. Follow-up (meanly 1 year after prosthesis reimplantation 
[155/744 days]) 
2.1 Physical examination 
Maximal walking distance: 
4 patients reported an unlimited walking dis-
tance, 2 patients were mobile only in their homes. One 
patient reported a walking distance of 200 m, how-
ever, he was dependent on a walking aid. One patient 
reported a weather-dependent insecurity beyond a 
distance of 200 m. 
Pain: 
5 patients were painfree, one patient had mod-
erate complaints after long walks. The other two pa-
tients reported of minor pain during mobilisation 
with crutches. 
Walking aid: 
3 patients did not need any aid at all, one patient 
used an aid outdoors. One patient was dependent on 
an aid all the time due to a gluteal insufficiency. The 
other three patients were immobile during the im-
plantation period and showed only minimal mobility 
with a walking frame. 
Leg length discrepancy: 
At follow-up, a leg length discrepancy between 1 
and 2.5 cm could be noticed in 3 patients, whereby in 
2 out of the 3 cases this discrepancy has been de-
creased compared with the values before the spacer 
implantation, respectively. 
3. Scores 
3.1. Joint specific outcome 
3.1.1 Merle d´Aubigné and Postel hip score (Fig. 2) 
The evaluation of the Merle d´Aubigné and 
Postel hip score showed significant increases between 
the infection situation and the period between stages 
(p < 0.021) and the prosthesis reimplantation (p < 
0.018), respectively. In regard to the score dimension 
“pain”, a significant increase (p < 0.018) between the 
infection situation and the period between stages 
could be achieved, but not to the prosthesis implanta-
tion. 
3.1.2. Mayo hip score after Kavanagh und Fitzgerald (Fig. 3) 
The evaluation of the Mayo hip score showed 
also a significant increase between the infection situa-
tion and the period between stages (p < 0.028) and the 
prosthesis reimplantation (p < 0.018), respectively. 
Moreover, a significant increase (p < 0.026) has been 
noticed for the dimension “pain” after spacer im-
plantation. 
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Fig. 2: Evaluation of the hip joint function by the Merle d’ Aubigne score at the site of spacer implantation in the treatment 
of proximal femur infections. 
 
 
Fig. 3: Evaluation of the hip joint function by the Mayo Hip Score at the site of spacer implantation in the treatment of 
proximal femur infections. 
 
3.2. General outcome 
3.2.1 SF-36 
In the areas „ physical fitness“ and “physical role 
function“ the achieved values were below those of the 
control group. Regarding “pain”, “general health 
condition”, “social integration”, “emotional role 
function” and “mental well-being” they were beyond 
of those of the control group. Significant statistical test 
series could not be performed due to the small num-Int. J. Med. Sci. 2009, 6 
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ber of patients. 
Discussion 
The implantation of temporary, antibiotic-loaded 
PMMA prostheses is accepted for an adequate option 
in the treatment of periprosthetic infections. Although 
their indication for the treatment of destructive, bac-
terial infections of the proximal femur would make 
sense, literature data are scarce [8-9]. Thus, the aim of 
this article was to study the efficacy of antibi-
otic-loaded PMMA-hip spacers in the treatment of 
infections of the proximal femur.  
Isiklar and colleagues were the first to report on 
the successful use of a hip spacer in the treatment of 
an infected femoral neck fracture with implant failure 
and pseudarthrosis [9]. Hsieh et al. treated 27 patients 
with deep hip infections following failed primary 
treatment of an intertrochanteric fracture with a 
two-stage protocol [8]. In the first 15 cases antibi-
otic-loaded beads have been implanted after resection 
arthroplasty, whereas the remaining 12 patients have 
been treated by implantation of an antibi-
otic-impregnated hip spacer. At an average follow-up 
of 4.8 years one reinfection could be observed in one 
patient in the first group. During the interim period, 
patients with a spacer prosthesis has significantly 
higher hip scores and better mobility after evaluation 
by the Merle d´Aubigné and Postel hip score. Similar 
to these data, we could not observe any reinfection or 
infection persistence in our patients’ series. 
The Girdlestone-hip (excision arthroplasty of the 
femoral head) with the subsequent insertion of local 
antibiotic-impregnated media is still counting among 
the standard treatment options of the destructive, 
bacterial coxitis [16-18, 20]. It is also performed in the 
treatment of the septic femoral neck pseudarthrosis. 
Frequently, pathogen organisms as tuberculosis and 
salmonella bacteria can be isolated from such infec-
tions [6, 13, 18, 20, 23]. With regard to these organisms 
and the increasing ratio of multiresistant bacteria 
[11-12, 25] a local antibiosis has become difficult to 
apply. Especially the ratio of multiresistant bacteria 
strains, as staphylococci, streptococci and enterococci, 
has increased [25-27]. These organisms were respon-
sible for all infections in our patients. Commercially 
available antibiotic-loaded media (beads, collagen 
sponges) are loaded only with gentamicin. Therefore, 
the addition of an antibiotic to PMMA is required for 
enhancement of the antibiotic therapy which is possi-
ble using our treatment option. 
To our knowledge, there exists only one study 
which compared the Girdlestone procedure with the 
spacer implantation with regard to the clinical out-
come, surgical parameters and follow-up [7]. Al-
though no significant difference could be observed 
regarding the infection eradication rate, many authors 
are in favour of the spacer procedure at the site of a 
two-stage protocol [5, 14, 24]. Especially the physio-
therapeutical measurements can be performed better 
due to the spacer-induced joint stability [24]. The 
lacking leg length discrepany allows an almost 
physiological joint mobility which could serve in the 
prophylaxis of pneumonia and thrombosis [22]. Fur-
thermore, some authors permit a partial weight 
bearing with the spacer [5, 19, 24], which can be per-
formed painfree in most cases, in contrast to the exci-
sion arthroplasty [16]. A disuse osteoporosis and 
muscle atrophy are hereby prevented so that the later 
prosthesis reimplantation is facilitated [29]. In con-
clusion, the spacer implantation optimizes the prem-
ises for a successful reimplantation of the prosthesis 
with regard to the heart and circulation situation and 
the biomechanical properties.  
Despite these advantages, no significant increase 
could be observed in our collective for the score di-
mension “mobility” between stages. On the contrary, 
the score values at follow-up showed an increase 
compared to pre- and during spacer implantation. A 
probable cause might be the reduced weight bearing 
properties of our spacer. Therefore, the enhancement 
of the spacer’s stability should be the aim of further 
investigations, either with the insertion of a metallic 
endoskeleton or with K-wires [7-8, 14, 19]. 
Regarding the score dimension “pain” our pa-
tients showed significantly better results after the 
spacer implantation than before. Hereby, the articu-
lating grinding of the spacer´s head against the 
acetabulum seems to be of no disadvantage. The pain 
reduction might result from the intra-articular pres-
sure decrease due to the arthrotomy and head resec-
tion or the joint stability guaranteed by the spacer. 
The evaluation of the follow-up results of the 
remaining parameters (walking aid, walking distance, 
joint mobility) showed satisfactory results. In only one 
case we could observe an unsatisfactory outcome. In 
particular, the consecutive complications (fracture of 
the dorsal acetabular lip, spacer dislocation, throm-
bosis, reinfection) had a negative influence on the 
outcome. The reinfection after the prosthesis reim-
plantation should not be attributed as a failure of the 
spacer treatment, because the reinfection rate after 
Girdlestone arthroplasty with 16.1 % [30] is higher 
than in our series. 
The evaluation of the health-related life quality 
by the SF-36 showed that the values of the physical 
fitness and the physical role function were lower than 
those of the control group. These two scales reflect the 
health condition for normal and exhausting physical Int. J. Med. Sci. 2009, 6 
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activity. In the scales “physical pain”, “general health 
perception”, “vitality”, “social integration”, “emo-
tional role function” and “mental well-being” the 
values achieved were among the norm values. With 
regard to the health condition of the patients, our re-
sults indicate that the physical activity is affected after 
several operations. However, these affections do not 
have any severe influence on the normal social activ-
ity or create any emotional problems. 
Conclusion 
Spacers could be indicated in the treatment of 
proximal femur infections. Beyond the infection 
eradication a pain reduction is possible due to the 
spacer implantation. The mobility of the patients be-
tween stages could be enhanced by improving the 
spacer’s mechanical properties.  
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